Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biocompatibility is defined as the ability of a material to perform with an appropriate host response in a specific application. It is not a single molecular target, receptor, or enzyme, but rather a complex property of biomaterials used in medical devices, implants, and drug delivery systems. The assessment of biocompatibility involves evaluating how a material interacts with various biological components, including blood, tissues, and the immune system, to ensure that it does not cause unacceptable harm or adverse reactions such as toxicity or rejection (Williams, 2008). These interactions are dictated by the material's surface chemistry, topography, and mechanical properties. Because biocompatibility is a situational property rather than a biological molecule, it cannot be 'targeted' by drugs in the traditional sense; instead, it is a requirement that therapeutic systems must satisfy to be safely used in humans (ISO 10993-1:2018). Failure to maintain biocompatibility can lead to chronic inflammation, fibrous encapsulation, or systemic toxicity.
Not applicable as biocompatibility is a property of a material's interaction with a biological system rather than a drug target mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biocompatibility.